Projects per year
Personal profile
Biography
Jing Jing is a Senior Research Fellow at the Centre for Health Economics, Monash University Business School. She leads the Monash University Health Technology Assessment team, conducting evaluations that inform funding decisions for health technologies globally, including for the Pharmaceutical Benefits Advisory Committee (PBAC), Medical Services Advisory Committee (MSAC), the Australian Technical Advisory Group on Immunisation (ATAGI), and the Agency for Care Effectiveness in Singapore. Her research focuses on healthcare decision-making, cancer care, cost-effectiveness analysis alongside clinical trials, and advanced decision analytic modelling.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Health Economics
- Clinical Trials
- Decision analytic modelling
- Economic Evaluation
- Decision Analysis
- cancer
- Health Technology Assessments
- Outcomes Assessment (Health Care)
- Decision Analytic Modelling
- Decision Making Modelling
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
ACE evaluation for a rare genetic disorder that increases risks for various cancers
Li, J. J. (Primary Chief Investigator (PCI)), Ghijben, P. (Chief Investigator (CI)) & Huxley, N. (Chief Investigator (CI))
1/05/25 → 30/04/26
Project: Research
-
Tools to value health change in paediatric populations
Li, J. J. (Primary Chief Investigator (PCI)) & Lancsar, E. (Chief Investigator (CI))
1/06/24 → 17/07/25
Project: Research
-
Provision of External Evaluation of Pharmaceutical Benefits Advisory Committee (PBAC) and Health Techology Related Submission
Li, J. J. (Primary Chief Investigator (PCI)), Ghijben, P. (Chief Investigator (CI)) & Harris, A. (Chief Investigator (CI))
1/07/21 → 30/06/25
Project: Research
-
Monitoring system for final trial overall survival (OS) results for cancer medicines
Li, J. J. (Primary Chief Investigator (PCI)), Sia, K. L. (Chief Investigator (CI)), Ghijben, P. (Chief Investigator (CI)), Petrie, D. (Chief Investigator (CI)), Picton, L. (Chief Investigator (CI)), Yong, K. (Chief Investigator (CI)), Chen, E. (Chief Investigator (CI)) & Ayati, N. (Chief Investigator (CI))
24/06/24 → 30/04/25
Project: Research
-
ACE evaluation for breast cancer
Li, J. J. (Primary Chief Investigator (PCI)), Woode, M. E. (Chief Investigator (CI)) & Petrie, D. (Chief Investigator (CI))
1/06/24 → 31/12/24
Project: Research
-
Radiotherapy and theranostics: a Lancet Oncology Commission
Abdel-Wahab, M., Giammarile, F., Carrara, M., Paez, D., Hricak, H., Ayati, N., Li, J. J., Mueller, M., Aggarwal, A., Al-Ibraheem, A., Alkhatib, S., Atun, R., Bello, A., Berger, D., Delgado Bolton, R. C., Buatti, J. M., Burt, G., Bjelac, O. C., Cordero-Mendez, L. & Dosanjh, M. & 32 others, , Nov 2024, In: The Lancet Oncology. 25, 11, p. e545-e580 36 p.Research output: Contribution to journal › Review Article › Research › peer-review
35 Citations (Scopus) -
A Review of Cancer Related Surrogate Outcomes Used For PBAC Decision Making: The Cancer Surrogate Report for the PBAC
Sia, K.-L., Picton, L., Chen, E., Yong, K., Petrie, D., Ghijben, P., Mohanannair Geethadevi, G., Winn, K. M., Crothers, A. & Li, J. J., Jul 2023, Australia: Commonwealth Department of Health and Aged Care. 85 p.Research output: Book/Report › Commissioned Report › Other
Open Access -
Post-market Review of medicines for smoking cessation: ToR 4: Cost-effectiveness review of specified combinations of smoking cessation medicines and estimates for the Pharmaceutical Benefits Scheme
Petrie, D., Ghijben, P., Li, J. J., Chen, E., Sia, K. L., Saxby, K. & Ireland, A., 22 Dec 2022, Australia: Commonwealth Department of Health and Aged Care. 86 p.Research output: Book/Report › Commissioned Report › Other
Open Access -
What can we expect from value-based funding of medicines? A retrospective study
Harris, A. H., Li, J. J. & Yong, K. K. L., 2016, In: PharmacoEconomics. 34, 4, p. 393 - 402 10 p.Research output: Contribution to journal › Article › Research › peer-review
11 Citations (Scopus) -
Effect of timing of dialysis commencement on clinical outcomes of patients with planned initiation of peritoneal dialysis in the ideal trial
Johnson, D. W., Wong, M. G., Cooper, B. A., Branley, P., Bulfone, L., Collins, J. F., Craig, J. C., Fraenkel, M., Harris, A. H., Kesselhut, J., Li, J. J., Luxton, G., Pilmore, A., Tiller, D. J., Harris, D. C. & Pollock, C. A., 2012, In: Peritoneal Dialysis International. 32, 6, p. 595 - 604 10 p.Research output: Contribution to journal › Article › Research › peer-review
33 Citations (Scopus)
Prizes
-
Business School Commendation for Research Impact 2020
Li, J. J. (Recipient), 2020
Prize: Prize (including medals and awards)